Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug2178 | Loss Frame and Fear Appeals Wiki | 0.71 |
| drug3647 | Small Gift Wiki | 0.71 |
| drug4436 | congenital malformation Wiki | 0.71 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D003141 | Communicable Diseases NIH | 0.05 |
| D018352 | Coronavirus Infections NIH | 0.05 |
| D007239 | Infection NIH | 0.03 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There are 2 clinical trials
Annual Wellness Visits (AWVs) are a type of detailed healthcare checkup to which Medicare beneficiaries are entitled, free of charge, once per year. The purpose of the current study is to assess what content and communication modality results in the most effective messaging campaign to encourage Medicare beneficiaries to schedule their AWVs.
Description: Patient scheduled an AWV appointment
Measure: Proportion of patients who scheduled an AWV appointment Time: 1 month after start of interventionDescription: Patient completed an AWV
Measure: Proportion of patients who completed an AWV visit Time: 3 months after start of interventionDescription: Patient scheduled an AWV appointment
Measure: Proportion of patients who scheduled an AWV appointment Time: 3 months after start of interventionDescription: Patient called one of the phone numbers provided on postcards regarding AWV
Measure: Proportion of patients who initiated contact Time: 3 months after start of interventionDescription: Whether patient AWV was in person or a telehealth visit
Measure: Proportion of visits that were in-person vs. tele-visit Time: 3 months after start of interventionDescription: Cost of campaign for whole study arm divided by number of patients who completed an AWV for that study arm.
Measure: Per patient campaign cost Time: 3 months after start of interventionIn this evaluation, 3 different versions of mailers promoting annual mammograms are being sent to women on the month of their 50th and 64th birthdays. The researchers hypothesize that the use of behavioral nudges in the mailers should lead to increased uptake in mammogram screening.
Description: Binary variable indicating whether a mammogram was completed
Measure: Mammogram Completion at 6 months (2020) Time: 6 months from intervention start dateDescription: Binary variable indicating whether a mammogram was completed (a longer time frame allows for late responses)
Measure: Mammogram Completion at 12 months (2020) Time: 12 months from intervention start dateDescription: Number of visits (proxy for increased preventative health care)
Measure: Primary Care Provider Visits at 6 months (2020) Time: 6 months from intervention start dateDescription: Number of visits (proxy for increased preventative health care)
Measure: Primary Care Provider Visits at 12 months (2020) Time: 12 months from intervention start dateDescription: Number of visits (proxy for increased preventative health care)
Measure: Obstetrician-Gynecologist Visits at 6 months (2020) Time: 6 months from intervention start dateDescription: Number of visits (proxy for increased preventative health care)
Measure: Obstetrician-Gynecologist Visits at 12 months (2020) Time: 12 months from intervention start dateDescription: Binary variable indicating whether the recipient was diagnosed with breast cancer
Measure: Breast Cancer Diagnosis at 6 months (2020) Time: 6 months from intervention start dateDescription: Binary variable indicating whether the recipient was diagnosed with breast cancer
Measure: Breast Cancer Diagnosis at 12 months (2020) Time: 12 months from intervention start dateDescription: Number of Emergency Department Visits (proxy for increased costly utilization of health system resources)
Measure: Emergency Department Visits at 6 months (2020) Time: 6 months from intervention start dateDescription: Number of Emergency Department Visits (proxy for increased costly utilization of health system resources)
Measure: Emergency Department Visits at 12 months (2020) Time: 12 months from intervention start dateDescription: Binary variable indicating whether a mammogram was completed to be used for exploratory pre-post comparisons
Measure: Mammogram Completion at 12 months (2019) Time: 12 months from 2019 intervention start dateDescription: Number of visits to be used for exploratory pre-post comparisons (proxy for increased preventative health care)
Measure: Primary Care Provider Visits at 12 months (2019) Time: 12 months from 2019 intervention start dateDescription: Binary variable indicating whether the woman was diagnosed with breast cancer
Measure: Breast Cancer Diagnosis at 12 months (2019) Time: 12 months from 2019 intervention start dateDescription: Number of Emergency Department Visits (proxy for increased costly utilization of health system resources)
Measure: Emergency Department Visits at 12 months (2019) Time: 12 months from 2019 intervention start dateAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports